|
|
||||||||
Original Articles |
Noninvasive markers of airway inflammation are needed for use in research and clinical practice in childhood asthma. Induced sputum and exhaled nitric oxide are well established as direct markers of inflammation for use in asthma research. Sputum can be induced from children of >6 yrs using inhalation of hypertonic saline, and, if appropriate, can be combined with an assessment of airway responsiveness to hypertonic saline. The success rate of sputum induction in children is 68-100%. Most studies have processed sputum using the plug selection method, and show that the dominant cell in sputum from normal children is the macrophage, and that the upper normal limit for sputum eosinophils in children is 2.5%. The inflammatory response in childhood asthma is characterized by elevated numbers of sputum eosinophils, and eosinophil cationic protein concentration, as well as increased nitric oxide and hydrogen peroxide levels in exhaled breath. Sputum eosinophils correlate with objective markers of disease severity in steroid-naive children with asthma, and in severe asthma. Inflammatory marker levels are lower in children using glucocorticosteroids. Induced sputum and exhaled gases are important markers of inflammation in childhood asthma. The clinical utility of these markers warrants further study.
This article has been cited by other articles:
![]() |
A M Li, E Hung, T Tsang, J Yin, H K So, E Wong, T F Fok, and P C Ng Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea Thorax, January 1, 2007; 62(1): 75 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Birrell, K. McCluskie, E. Hardaker, R. Knowles, and M. G. Belvisi Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Eur. Respir. J., December 1, 2006; 28(6): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Wood, M. L. Garg, R. J. Blake, S. Garcia-Caraballo, and P. G. Gibson Airway and Circulating Levels of Carotenoids in Asthma and Healthy Controls J. Am. Coll. Nutr., December 1, 2005; 24(6): 448 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. MacGregor, S. Ellis, J. Andrews, M. Imrie, A. Innes, A. P. Greening, and S. Cunningham Breath condensate ammonium is lower in children with chronic asthma Eur. Respir. J., August 1, 2005; 26(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ratnawati and P S Thomas Exhaled nitric oxide in paediatric asthma Chronic Respiratory Disease, July 1, 2005; 2(3): 163 - 174. [Abstract] [PDF] |
||||
![]() |
L. G. Wood, M. L. Garg, J. L. Simpson, T. A. Mori, K. D. Croft, P. A. B. Wark, and P. G. Gibson Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 426 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Morice and J A Kastelik Cough * 1: Chronic cough in adults Thorax, October 1, 2003; 58(10): 901 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
L P Malmberg, A S Pelkonen, T Haahtela, and M Turpeinen Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma Thorax, June 1, 2003; 58(6): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P G Gibson, J L Simpson, R Hankin, H Powell, and R L Henry Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma Thorax, February 1, 2003; 58(2): 116 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
F L M Ricciardolo Multiple roles of nitric oxide in the airways Thorax, February 1, 2003; 58(2): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Fabbri, M. Romagnoli, L. Corbetta, G. Casoni, K. Busljetic, G. Turato, G. Ligabue, A. Ciaccia, M. Saetta, and A. Papi Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.G. Wood, P.G. Gibson, and M.L. Garg Biomarkers of lipid peroxidation, airway inflammation and asthma Eur. Respir. J., January 1, 2003; 21(1): 177 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-P. Boulet, V. Boulet, and J. Milot How Should We Quantify Asthma Control?: A Proposal Chest, December 1, 2002; 122(6): 2217 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Leader of the Working Group:, J.C. Kips, Members of the Working Group:, M.D. Inman, L. Jayaram, E.H. Bel, K. Parameswaran, M.M.M. Pizzichini, I.D. Pavord, R. Djukanovic, et al. The use of induced sputum in clinical trials Eur. Respir. J., July 1, 2002; 20(37_suppl): 47S - 50s. [Full Text] [PDF] |
||||
![]() |
P. D. JONES, R. HANKIN, J. SIMPSON, P. G. GIBSON, and R. L. HENRY The Tolerability, Safety, and Success of Sputum Induction and Combined Hypertonic Saline Challenge in Children Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1146 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |